Literature DB >> 23074435

Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.

.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23074435      PMCID： PMC3384376     

Source DB:  PubMed          Journal:  Ont Health Technol Assess Ser        ISSN： 1915-7398


× No keyword cloud information.
  45 in total

1.  Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation.

Authors:  A J Crockett; J M Cranston; J R Moss; J H Alpers
Journal:  Monaldi Arch Chest Dis       Date:  1999-04

Review 2.  Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand.

Authors:  Christine F McDonald; Alan J Crockett; Iven H Young
Journal:  Med J Aust       Date:  2005-06-20       Impact factor: 7.738

3.  Randomised trial of ambulatory oxygen in oxygen-dependent COPD.

Authors:  Y Lacasse; R Lecours; C Pelletier; R Bégin; F Maltais
Journal:  Eur Respir J       Date:  2005-06       Impact factor: 16.671

Review 4.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

Review 5.  Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful?

Authors:  Nicholas J Gross
Journal:  Proc Am Thorac Soc       Date:  2005

6.  Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia?

Authors:  A A Okubadejo; E A Paul; P W Jones; J A Wedzicha
Journal:  Eur Respir J       Date:  1996-11       Impact factor: 16.671

Review 7.  Domiciliary oxygen for chronic obstructive pulmonary disease.

Authors:  J M Cranston; A J Crockett; J R Moss; J H Alpers
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

8.  Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study.

Authors:  T Eaton; W Fergusson; J Kolbe; C A Lewis; T West
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

9.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease.

Authors:  R Kessler; M Faller; G Fourgaut; B Mennecier; E Weitzenblum
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

10.  Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia.

Authors:  C F McDonald; C M Blyth; M D Lazarus; I Marschner; C E Barter
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405
View more
  4 in total

Review 1.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

Review 2.  Health technologies for the improvement of chronic disease management: a review of the Medical Advisory Secretariat evidence-based analyses between 2006 and 2011.

Authors:  M Nikitovic; S Brener
Journal:  Ont Health Technol Assess Ser       Date:  2013-09-01

Review 3.  Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction.

Authors:  Alessandro Celi; Manuela Latorre; Pierluigi Paggiaro; Riccardo Pistelli
Journal:  Ther Adv Chronic Dis       Date:  2021-05-13       Impact factor: 5.091

4.  The clinical and economic burden of chronic obstructive pulmonary disease in the USA.

Authors:  Anthony J Guarascio; Shauntá M Ray; Christopher K Finch; Timothy H Self
Journal:  Clinicoecon Outcomes Res       Date:  2013-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.